Study on risk factors, predictive models and preventive measures of postoperative sleep disorders

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2300078231

Enrollment

Unknown

Registered

2023-12-01

Start date

2023-12-01

Completion date

Unknown

Last updated

2023-12-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Convalescence

Interventions

Experimental group (dexmedetomidine group):0.2µg/kg/h dexmedetomidine

Control group (saline group):The same amount of saline

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Adults over 18 years old; Receiving surgical treatment under general anesthesia; American Society of Anesthesiologists grade I to III.

Exclusion criteria

Exclusion criteria: Have taken sedatives or antidepressants within the last 1 month; Admitted to the intensive care unit after surgery; Unable to cooperate with follow-up due to various reasons; There are contraindications with the intended anesthetic.

Design outcomes

Primary

Measure	Time frame
Incidence of postoperative sleep disorders on day 1 and day 3 after surgery;	—

Secondary

Measure	Time frame
VAS scores at rest and movement 24 and 48 hours after surgery;total morphine consumption 24 and 48 hours after surgery;anxiety and depression scores on day 1 and day 3 after surgery;incidence of delirium 7 days after surgery;	—

Countries

China

Contacts

Public ContactTANG XIAONING

The First Affiliated Hospital of Chongqing Medical University

txn@hospital.cqmu.edu.cn+86 150 2361 6471

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026